Interindividual variability of response to rituximab: from biological origins to individualized therapies, Clin Cancer Res, vol.17, pp.19-30, 2011. ,
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene, Blood, vol.99, pp.754-758, 2002. ,
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression, J Clin Invest, vol.118, pp.3420-3430, 2008. ,
A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses, Immunity, vol.28, pp.639-650, 2008. ,
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells, Blood, vol.117, pp.530-541, 2011. ,
Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function, Leukemia, vol.27, pp.170-182, 2013. ,
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines, Blood, vol.111, pp.5446-5456, 2008. ,
Results of a Phase II Randomizing Intensified Rituximab Pre-Phase Followed By Standard FCR Vs Standard FCR in Previously Untreated Patients with Active B-Chronic Lymphocytic Leukemia (B-CLL). CLL2010FMP (for fit medically patients): A Study of the French Cooperative Group on CLL and WM (FCGCLL/MW) and the "Groupe Ouest-Est d'Etudes Des Leucémies Aigües Et Autres Maladies Du sang, 56th ASH Annual Meeting, p.3329, 2014. ,
Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions, N Engl J Med, vol.370, pp.1101-1110, 2014. ,
Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice, J Clin Invest, vol.121, pp.4268-4280, 2011. ,
, The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material, Blood Cancer Journal website